These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2884568)

  • 21. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M; Kettler R; Keller HH; Bonetti EP; Imhof R
    Adv Neurol; 1987; 45():175-8. PubMed ID: 2881442
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
    Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
    Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
    D'Amato RJ; Benham DF; Snyder SH
    J Neurochem; 1987 Feb; 48(2):653-8. PubMed ID: 3491879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
    Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipid peroxidation in the caudate nuclei in experimental parkinsonian syndrome].
    Kucherianu VG; Atadzhanov MA; Nikushkin EV; Zagorevskiĭ VA; Sharkova LM
    Biull Eksp Biol Med; 1989 Jan; 107(1):39-41. PubMed ID: 2783652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
    Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW
    Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
    Imai H; Nakamura T; Endo K; Narabayashi H
    Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
    Cohen G; Pasik P; Cohen B; Leist A; Mytilineou C; Yahr MD
    Eur J Pharmacol; 1984 Oct; 106(1):209-10. PubMed ID: 6442232
    [No Abstract]   [Full Text] [Related]  

  • 37. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE; Hess A; Duvoisin RC
    Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partially protective effect of amantadine in the MPTP model of Parkinson's disease.
    Rojas P; Altagracia M; Kravsov J; Rios C
    Proc West Pharmacol Soc; 1992; 35():33-5. PubMed ID: 1502234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.